Disclosure Panels Details Page
Neuroendocrine Tumors Panel - Disclosures as of 01/22/2021
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Sarimar Agosto Salgado MD | Bayer HealthCare Lilly/Loxo Oncology |
Blueprint Medicines Eisai Inc. |
None | None | ✔ |
| Al Benson III MD, FACCC, FACP, FASCO | None | None | None | None | ✔ |
| Emily Bergsland MD | Merck & Co., Inc. | Advanced accelerator applications | MoreHealth | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Lawrence Blaszkowsky MD | None | None | None | Pfizer Inc. | - |
| Pamela Brock MS, LGC | Ohio State University | None | None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Jennifer Chan MD | Eli Lilly and Company Exelixis Inc. Merck & Co., Inc. sanofi-aventis U.S. Tarveda |
Advanced Accelerator Applications (a Novartis company) Bayer HealthCare Lexicon Pharmaceuticals, Inc. Pfizer Inc. |
None | Merck & Co., Inc. | ✔ |
| Satya Das MD, MSCI | None | Cancer Expert Now | Ipsen | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Paxton Dickson MD | None | None | None | None | - |
| Paul Fanta MD | None | None | None | None | - |
| Thomas Giordano MD, PhD | None | None | None | None | - |
| Whitney Goldner MD | Roche Laboratories, Inc. | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Thorvardur Halfdanarson MD | Advanced Accelerator Applications Agios, Inc. Basilea Thermo Fisher Scientific |
Advanced Accelerator Applications Curium Ipsen Lexicon Pharmaceuticals, Inc. ScioScientific TERUMO |
None | None | ✔ |
| Daniel Halperin MD | Advanced Accelerator Applications Genentech, Inc. Incyte Corporation Tarveda TerSera ThermoFisher Scientific |
Advanced Accelerator Applications Curium Ipsen Isotopen Technologien München AG Lexicon Pharmaceuticals, Inc. McGraw Hill |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jin He MD, PhD | None | None | None | None | ✔ |
| Anthony Heaney MD, PhD | camarus chiasma corcept Ipsen strongbridge |
chiasma corcept |
None | None | ✔ |
| Martin Heslin MD | None | None | Best Doctors, Inc | None | - |
| Cindy Hochstetler PhD | None | None | None | None | ✔ |
| Anne Holbrook PharmD, BCOP | None | None | None | None | - |
| Fouad Kandeel MD, PhD | None | None | None | None | - |
| Arash Kardan MD | None | None | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Sajid Khan MD | None | None | None | None | ✔ |
| Boris Kuvshinoff MD, MBA | None | None | None | None | ✔ |
| Christopher Lieu MD | None | HalioDx | None | None | ✔ |
| Daniel Lui PharmD, BCPPS | None | None | Brand Institute Inc M3 MedPanel MNOW (Sermo) Reckner |
None | - |
| Beth McCullough RN, BS, CMSRN | None | None | None | None | ✔ |
| Kimberly Miller RN | None | None | None | None | - |
| Sukhmani Padda MD | Bayer HealthCare Boehringer Ingelheim GmbH Epicentrx |
AstraZeneca Pharmaceuticals LP Blueprint Medicines G1 Therapeutic |
None | None | - |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Venu Pillarisetty MD | AstraZeneca Pharmaceuticals LP Ipsen Merck & Co., Inc. |
Takeda Pharmaceuticals North America, Inc. | None | None | - |
| James Polson BSRT (R) (CT) (MR) | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Diane Reidy-Lagunes MD | Ipsen Lexicon Pharmaceuticals, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
None | None | None | ✔ |
| Manisha Shah MD | Eli Lilly and Company Merck & Co., Inc. |
None | None | None | ✔ |
| Shagufta Shaheen MD | None | Ipsen Virtual Advisory Board for ASCO Virtual Direct™ Highlights San Francisco |
None | None | ✔ |
| Heloisa Soares MD, PhD | None | Advanced Accelerator Applications Exelixis Inc. Ipsen Lexicon Pharmaceuticals, Inc. Natera QED Therapeutics |
None | None | ✔ |
| Michael Soulen MD, FCIRSE, FSIR | Guerbet LLC | Guerbet LLC Instylla Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Jonathan Strosberg MD | None | None | Novartis Pharmaceuticals Corporation | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | ✔ |
| Craig Sussman MD | None | None | None | None | ✔ |
| Nikolaos Trikalinos MD | None | None | None | None | ✔ |
| Nataliya Uboha MD, PhD | Eli Lilly and Company EMD Serono Ipsen Taiho Pharmaceuticals Co., Ltd. |
AstraZeneca Pharmaceuticals LP Incyte Corporation Ipsen QED Taiho Pharmaceuticals Co., Ltd. |
None | None | ✔ |
| Namrata Vijayvergia MD, FACP | None | None | Halio Dx Lexicon Pharmaceuticals, Inc. |
None | ✔ |
| Terence Wong MD, PhD, FACR | None | None | None | None | ✔ |